E P Gurfinkel

Summary

Country: Argentina

Publications

  1. ncbi Presence of vulnerable coronary plaques in middle-aged individuals who suffered a brain death
    Enrique Gurfinkel
    Department of Cardiovascular Medicine Fundacion Favaloro, and Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET, Buenos Aires, Argentina
    Eur Heart J 30:2845-53. 2009
  2. ncbi Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry
    Enrique P Gurfinkel
    Foundation Favaloro, Buenos Aires, Argentina
    Tex Heart Inst J 31:28-32. 2004
  3. ncbi Prevention of myocardial infarction
    Enrique P Gurfinkel
    Institute of Cardiology and Cardiovascular Surgery, Fundacion Favaloro, Buenos Aires, Argentina
    Curr Opin Cardiol 21:503-9. 2006
  4. ncbi Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery
    Enrique P Gurfinkel
    ICyCC Fundación Favaloro, Av Belgrano 1746 1093 Capital Federal, Buenos Aires, Argentina
    Int J Cardiol 119:65-72. 2007
  5. ncbi Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study
    Enrique P Gurfinkel
    Fundacion Favaloro, Capital Federal, Buenos Aires, Argentina
    Circulation 105:2143-7. 2002
  6. ncbi Advances in coronary heart disease surgery in Latin America
    Enrique P Gurfinkel
    Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
    Circulation 115:1147-53. 2007
  7. ncbi Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study
    Enrique P Gurfinkel
    Foundation Favaloro, Av Belgrano 1746 1093, Capital Federal, Buenos Aires, Argentina
    Eur Heart J 25:25-31. 2004
  8. ncbi Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time
    G E Bozovich
    Favaloro Foundation, Buenos Aires, and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Am Heart J 140:637-42. 2000
  9. ncbi Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin
    E P Gurfinkel
    Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
    Am Heart J 140:E12-8. 2000
  10. ncbi Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction
    E P Gurfinkel
    Favaloro Foundation, Buenos Aires, Argentina
    Am J Cardiol 83:515-8. 1999

Collaborators

Detail Information

Publications26

  1. ncbi Presence of vulnerable coronary plaques in middle-aged individuals who suffered a brain death
    Enrique Gurfinkel
    Department of Cardiovascular Medicine Fundacion Favaloro, and Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET, Buenos Aires, Argentina
    Eur Heart J 30:2845-53. 2009
    ..The prevalence and characteristics of these plaques in the middle-aged apparently healthy population are unknown...
  2. ncbi Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry
    Enrique P Gurfinkel
    Foundation Favaloro, Buenos Aires, Argentina
    Tex Heart Inst J 31:28-32. 2004
    ..05). Influenza vaccination may reduce the risk of death and ischemic events in patients admitted with acute coronary syndromes. There is also a beneficial trend in the quiescent phase of ischemia...
  3. ncbi Prevention of myocardial infarction
    Enrique P Gurfinkel
    Institute of Cardiology and Cardiovascular Surgery, Fundacion Favaloro, Buenos Aires, Argentina
    Curr Opin Cardiol 21:503-9. 2006
    ..However, most articles are focused categorically on evidence-based medicine and give no room for conceptual analyses. In this article, we attempt to review the main aspects of this theme from a different point of view...
  4. ncbi Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery
    Enrique P Gurfinkel
    ICyCC Fundación Favaloro, Av Belgrano 1746 1093 Capital Federal, Buenos Aires, Argentina
    Int J Cardiol 119:65-72. 2007
    ..We evaluated the association between invasive and non-invasive management and hospital and 6-month outcomes in patients with a prior coronary artery bypass graft (CABG) who experienced an acute coronary syndrome...
  5. ncbi Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study
    Enrique P Gurfinkel
    Fundacion Favaloro, Capital Federal, Buenos Aires, Argentina
    Circulation 105:2143-7. 2002
    ..We evaluated the preventive impact of vaccination on subsequent ischemic events in myocardial infarction patients and in subjects undergoing planned percutaneous coronary angioplasty...
  6. ncbi Advances in coronary heart disease surgery in Latin America
    Enrique P Gurfinkel
    Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
    Circulation 115:1147-53. 2007
    ..Since then, improvements in technique and greater experience have resulted in a rapid increase in the rate of interventions performed in the region...
  7. ncbi Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study
    Enrique P Gurfinkel
    Foundation Favaloro, Av Belgrano 1746 1093, Capital Federal, Buenos Aires, Argentina
    Eur Heart J 25:25-31. 2004
    ..To determine whether the observed benefits of vaccination against flu were maintained beyond the winter season a 1-year follow-up was conducted...
  8. ncbi Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time
    G E Bozovich
    Favaloro Foundation, Buenos Aires, and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Am Heart J 140:637-42. 2000
    ..Whether the clinical superiority of enoxaparin versus unfractionated heparin (UFH) depends on a more stable antithrombotic effect or the proportion of patients not reaching the therapeutic level with UFH has not been addressed...
  9. ncbi Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin
    E P Gurfinkel
    Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
    Am Heart J 140:E12-8. 2000
    ..We analyzed the effect of the pharmacologic combination of 2 indirect antithrombin drugs--enoxaparin (low-molecular-weight heparin) and unfractionated heparin--versus enoxaparin alone on the recurrence of ischemia...
  10. ncbi Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction
    E P Gurfinkel
    Favaloro Foundation, Buenos Aires, Argentina
    Am J Cardiol 83:515-8. 1999
    ..4807, p = 0.034). This study demonstrates a correlation between immune cell activation and the extent of angiographically determined atherosclerosis and the degree of myocardial ischemia...
  11. ncbi Emerging role of antibiotics in atherosclerosis
    E P Gurfinkel
    Coronary Care Unit, Fundacion Favaloro, Argentina
    Am Heart J 138:S537-8. 1999
    ..The ongoing WIZARD trial evaluates in a large population whether the addition of an antibiotic provides better outcome for coronary patients...
  12. ncbi Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial
    Marc Cohen
    Cardiac Cath Lab Administration, Newark Beth Israel Medical Center, Newark, NJ 07112, USA
    Circulation 108:III14-21. 2003
    ..Examination of prospectively gathered data on STEMI patients who are ineligible for reperfusion may help optimize their treatment...
  13. ncbi Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective
    Robert J Goldberg
    Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, 55 Lake Ave, Worcester, MA 01655, USA
    Arch Intern Med 167:1766-73. 2007
    ..Current practice guidelines recommend the routine use of several effective cardiac medications in hospital survivors of acute myocardial infarction (AMI)...
  14. ncbi Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)
    Melvin R Echols
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 99:315-21. 2007
    ..African-American patients had significantly better adjusted 30-day outcomes but similar 6-month outcomes compared with white patients...
  15. ncbi The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction
    Marc Cohen
    Cardiac Catheterization Laboratory, Newark Beth Israel Medical Center, 201 Lyons Avenue, Newark, New Jersey, 07112, USA
    J Thromb Thrombolysis 19:155-61. 2005
    ..We analyzed the impact of gender, and other factors, on the outcome and treatment of STEMI in the TETAMI trial and registry...
  16. ncbi Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE])
    Frederick A Spencer
    Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
    Am J Cardiol 90:1056-61. 2002
    ....
  17. ncbi [Flu vaccination in patients with acute coronary syndromes: treatment benefit in prespecified subgroups]
    Ricardo Leon de la Fuente
    Instituto de Cardiologia y Cirugia Cardiovascular, Fundacion Favaloro, Buenos Aires, Argentina
    Rev Esp Cardiol 56:949-54. 2003
    ....
  18. ncbi The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy
    Shaun G Goodman
    Division of Cardiology, Canadian Heart Research Centre, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
    Am Heart J 151:791-7. 2006
    ....
  19. ncbi The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)
    Shaun G Goodman
    Canadian Heart Research Centre, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
    Am Heart J 151:654-60. 2006
    ..The impact and prognostic value of the redefinition of myocardial infarction (MI) with more sensitive markers have not been evaluated prospectively in a large, less selected population with acute coronary syndrome (ACS)...
  20. ncbi The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial
    Marc Cohen
    Newark Beth Israel Medical Center, Newark, New Jersey 07112, USA
    J Am Coll Cardiol 42:1348-56. 2003
    ....
  21. ncbi Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events
    Jean-Philippe Collet
    Department of Cardiology, , Bureau 2-236, 47, , 75013 Paris, France
    Eur Heart J 26:2285-93. 2005
    ..Combination therapy with LMWH and GP IIb/IIIa inhibitors appears to be better tolerated than with UFH and GP IIb/IIIa inhibitors...
  22. ncbi Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study
    Kim A Eagle
    University of Michigan Cardiovascular Center, Ann Arbor, Michigan, USA
    Am J Med 117:73-81. 2004
    ..The reasons for noncompliance are complex, and may be elucidated by future studies of medical and social determinants...
  23. ncbi Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis
    Roberto R Giraldez
    TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 350 Longwood Avenue, 1st Floor, Boston, MA 02115, USA
    Eur Heart J 28:1566-73. 2007
    ..We compared outcomes of ST-elevation myocardial infarction (STEMI) patients randomized to a strategy of either enoxaparin or unfractionated heparin (UFH) to support fibrinolysis...
  24. ncbi Universal definition of myocardial infarction
    Kristian Thygesen
    Circulation 116:2634-53. 2007
  25. ncbi [Universal definition of the myocardial infarction.]
    Kristian Thygesen
    Department of Medicine and Cardiology, Aarhus University Hospital, Dania
    Kardiol Pol 66:47-62. 2008
  26. ncbi Suppression of life-threatening tachyarrhyhmias, and atrio-ventricular ischemic block following the administration of anti-inflammatory intravenous drug
    Enrique P Gurfinkel
    Int J Cardiol 114:E56-7. 2007
    ..In the present study, we found that administration of an anti-inflammatory compound (ibuprofen IV) during the electrical storm resulted in an immediate suppression of the threatening arrhythmias...